FMI Oral Solid Dosage Pharmaceutical Formulation Marke | Page 5

Oral Solid Dosage Pharmaceutical Formulation Market
paediatric forms, traditional blockbuster OSD products which are now off-patented will continue to
increase in demand for oral solid dosage pharmaceuticals. However, new chemical entities coming out of
discovery continue to have poor solubility and bioavailability challenges, high regulatory requirement for
high potency drugs, hard to swallow traditional solid tablets are expected to hinder the market growth
over forecast period.
Oral solid dosage pharmaceutical formulation market has been segmented on the basis of dosage form
type, drug releases pattern, distribution channel and region.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2782
Oral solid dosage pharmaceutical formulation market is undergoing market changes due to the higher
competition among key players and companies coming up with innovative and differential oral solid
dosage forms. Majority of the pharmaceutical companies are looking to more strategic partnerships,
acquisitions and mergers to consolidate market position. Companies are striving to increase the
production volumes to get advantage of the economies of scale, adoption of multiple continuous unit
operations are coupled into an integrated system application in the market place. Contract
Manufacturing Originations (CMO) and Contract Development Manufacturing Originations (CDMO) are
playing pivotal role in oral solid dosage pharmaceuticals value chain in the market place with its strong
expertise in formulation development. By dosage from type, sub segment such as tablets in the oral solid
dosage pharmaceutical formulation market is expected to grow in positive traction owing to its wider
application, ease of usage, availability and effectiveness in treating various ailments.
©2015 Future Market Insights, All Rights Reserved
5